Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7]

Catalogue Number: AB02325-44.0-BT-ABA

Manufacturer:Vector Laboratories, Inc (ABA)
Type:Recombinant Monoclonal
Alias:nucleoprotein; NP; NC; Protein N; Nucleocapsid protein; SARS-CoV Protein N; SARS-CoV-2 Nucleocapsid protein; SARS Coronavirus; SARS-CoV-2; SARS CoV 2; 2019-nCoV; 1C7; severe acute respiratory syndrome virus
Shipping Condition:Blue Ice
Unit(s): 500 ug
Host name: Cat
Clone: 1C7C7
Isotype: IgM
Immunogen: The original version of this antibody was raised against SARS-CoV-1/2.
Application: ELISA, FC, WB, IHC

Additional Text

Gene Name

N

Purification

Purified

Antibody Clonality

Recombinant Monoclonal

Gene ID

43740575

Uniprot ID

P0DTC9

Storage Note

Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C.

Application Notes

The antibody 1C7C7 detects SARS-CoV-2 and SARS-CoV-1 and can be used in affinity binding assays, flow cytometry, immunocytochemistry, and western blotting. Its effectiveness in detecting the nucleocapsid of the novel coronavirus causing COVID-19 was confirmed in multiple studies. For instance, it was used to analyze SARS-CoV-2 nucleoprotein extracted from infected cells via Western blot (Hoagland et al., 2020) ,and similarly by Blanco-Melo et al. in a study on imbalanced host response to SARS-CoV-2 (2020; pmid: 32416070). Another group has used this clone to stain infected cells fixed with 10% neutral formalin during a neutralization assay (Piepenbrink et al., 2020). Daniloski et al. performed similar staining procedure with 1C7C7 for a trans-complementation assay (2020; pmid: 33147445). Finally, this antibody was also used to stain SARs-CoV-2 infected cells in a study on in vitro susceptibility to SARS-CoV-2 infection (Dobrindt et al., 2020; pmid: 32995783).

Short Description

This chimeric cat antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.